Risk of venous thrombosis with hormone-replacement therapy

Affiliations

Comment

J P Vandenbroucke et al. Lancet. 1996.

. 1996 Oct 12;348(9033):972.

doi: 10.1016/S0140-6736(05)64918-5.

No abstract available

Comment in

Risk of venous thrombosis with hormone replacement therapy.
McKenna MJ. McKenna MJ. Lancet. 1996 Dec 14;348(9042):1668. doi: 10.1016/S0140-6736(05)65742-X. Lancet. 1996. PMID: 8962021 No abstract available.

Risk of venous thromboembolism in users of hormone replacement therapy.
Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Daly E, et al. Lancet. 1996 Oct 12;348(9033):977-80. doi: 10.1016/S0140-6736(96)07113-9. Lancet. 1996. PMID: 8855852
Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.
Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM. Jick H, et al. Lancet. 1996 Oct 12;348(9033):981-3. doi: 10.1016/S0140-6736(96)07114-0. Lancet. 1996. PMID: 8855853
Prospective study of exogenous hormones and risk of pulmonary embolism in women.
Grodstein F, Stampfer MJ, Goldhaber SZ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH. Grodstein F, et al. Lancet. 1996 Oct 12;348(9033):983-7. doi: 10.1016/S0140-6736(96)07308-4. Lancet. 1996. PMID: 8855854